In the last trading session, 1.74 million shares of the Mind Medicine Inc (NASDAQ:MNMD) were traded, and its beta was 1.77. Most recently the company’s share price was $6.07, and it changed around -$0.65 or -9.67% from the last close, which brings the market valuation of the company to $445.12M. MNMD currently trades at a discount to its 52-week high of $12.22, offering almost -101.32% off that amount. The share price’s 52-week low was $5.03, which indicates that the current value has risen by an impressive 17.13% since then.
Mind Medicine Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.10. If we narrow it down even further, the data shows that 0 out of 11 analysts rate the stock as a Sell; another 4 rate it as Overweight. Among the rest, 0 recommended MNMD as a Hold, whereas 7 deemed it a Buy, and 0 rated it as Underweight. Mind Medicine Inc is expected to report earnings per share of -0.28 for the current quarter.
Mind Medicine Inc (NASDAQ:MNMD) trade information
Instantly MNMD has showed a red trend with a performance of -9.67% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 7.21 on recent trading dayincreased the stock’s daily price by 15.81%. The company’s shares are currently down -12.79% year-to-date, but still down -15.46% over the last five days. On the other hand, Mind Medicine Inc (NASDAQ:MNMD) is -14.87% down in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $14, which translates to bulls needing to increase their stock price by 56.64% from its current value. Analyst projections state that MNMD is forecast to be at a low of $14 and a high of $14.
Forecasts for the next quarter put sales growth at 0.00%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 2.29%. Mind Medicine Inc earnings are expected to increase by 41.32% in 2025, but the outlook is positive 14.93% per year for the next five years.
MNMD Dividends
Mind Medicine Inc’s next quarterly earnings report is expected to be released in April.
iShares Russell 2000 ETF and Vanguard Extended Market Index Fund were the top two Mutual Funds as of Dec 31, 2024 . The former held 2.17 shares worth $13.15 million, making up 2.95% of all outstanding shares. On the other hand, Vanguard Extended Market Index Fund held roughly 1.05 shares worth around $6.38 million, which represents about 1.43% of the total shares outstanding.
